Status:
ENROLLING_BY_INVITATION
Molecular Profiling in Young (<50 Years of Age) Patients With Metastatic Breast Cancer
Lead Sponsor:
Seoul National University Hospital
Conditions:
Breast Cancer
Eligibility:
FEMALE
19-50 years
Phase:
NA
Brief Summary
Breast cancer is the most common cancer in women worldwide, especially in developed countries. In developing countries, including South Korea, the incidence and mortality rate of breast cancer is rapi...
Detailed Description
Secondary Objective(s): 1. To evaluate the prognostic and predictive role of tumor mutation burden. 2. To reveal the correlation between genetic characteristics and immunohistochemical expression of ...
Eligibility Criteria
Inclusion
- Patients between 19 - 50 years of age on the day of signing informed consent.
- Able to provide written informed consent for voluntary participation in the trial.
- With metastatic breast cancer
- Willing to provide biopsies from the primary tumor or lymph nodes at screening to the central laboratory. (with at least 10 unstained slides and 1 H\&E slide)
Exclusion
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the study.
Key Trial Info
Start Date :
September 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04098640
Start Date
September 23 2019
End Date
December 31 2025
Last Update
April 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, Seoul, South Korea, 110-744